Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model.

Kolosova NG, Kozhevnikova OS, Telegina DV, Fursova AZ, Stefanova NA, Muraleva NA, Venanzi F, Sherman MY, Kolesnikov SI, Sufianov AA, Gabai VL, Shneider AM.

Aging (Albany NY). 2018 Aug 28;10(8):2136-2147. doi: 10.18632/aging.101537.

2.

P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions.

Halenova T, Savchuk O, Ostapchenko L, Chursov A, Fridlyand N, Komissarov AB, Venanzi F, Kolesnikov SI, Sufianov AA, Sherman MY, Gabai VL, Shneider AM.

Oncotarget. 2017 Aug 3;8(34):56030-56040. doi: 10.18632/oncotarget.19840. eCollection 2017 Aug 22.

3.

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM.

Oncotarget. 2017 Mar 25;8(32):53730-53739. doi: 10.18632/oncotarget.16574. eCollection 2017 Aug 8.

4.

Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent.

Sabbieti MG, Agas D, Capitani M, Marchetti L, Concetti A, Vullo C, Catone G, Gabai V, Shifrin V, Sherman MY, Shneider A, Venanzi FM.

Oncotarget. 2015 Feb 28;6(6):3590-9.

5.

Pilot study of p62 DNA vaccine in dogs with mammary tumors.

Gabai V, Venanzi FM, Bagashova E, Rud O, Mariotti F, Vullo C, Catone G, Sherman MY, Concetti A, Chursov A, Latanova A, Shcherbinina V, Shifrin V, Shneider A.

Oncotarget. 2014 Dec 30;5(24):12803-10.

6.

Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.

Venanzi F, Shifrin V, Sherman M, Gabai V, Kiselev O, Komissarov A, Grudinin M, Shartukova M, Romanovskaya-Romanko EA, Kudryavets Y, Bezdenezhnykh N, Lykhova O, Semesyuk N, Concetti A, Tsyb A, Filimonova M, Makarchuk V, Yakubovsky R, Chursov A, Shcherbinina V, Shneider A.

Oncotarget. 2013 Oct;4(10):1829-35.

7.

Conservation of mRNA secondary structures may filter out mutations in Escherichia coli evolution.

Chursov A, Frishman D, Shneider A.

Nucleic Acids Res. 2013 Sep;41(16):7854-60. doi: 10.1093/nar/gkt507. Epub 2013 Jun 19.

8.

RNAtips: Analysis of temperature-induced changes of RNA secondary structure.

Chursov A, Kopetzky SJ, Bocharov G, Frishman D, Shneider A.

Nucleic Acids Res. 2013 Jul;41(Web Server issue):W486-91. doi: 10.1093/nar/gkt486. Epub 2013 Jun 12.

9.

Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus.

Chursov A, Kopetzky SJ, Leshchiner I, Kondofersky I, Theis FJ, Frishman D, Shneider A.

RNA Biol. 2012 Oct;9(10):1266-74. doi: 10.4161/rna.22081. Epub 2012 Sep 20.

10.

Sequence-structure relationships in yeast mRNAs.

Chursov A, Walter MC, Schmidt T, Mironov A, Shneider A, Frishman D.

Nucleic Acids Res. 2012 Feb;40(3):956-62. doi: 10.1093/nar/gkr790. Epub 2011 Sep 27.

11.

Creating a vision for nursing practice in a tertiary medical organization in Israel.

Porat N, Picker-Rotem O, Shneider A, Weingart-Eimerl E, Vaknin O, Toren O, Dayan G, Bartal N, Zelker R.

J Nurses Staff Dev. 2011 Jan-Feb;27(1):18-24. doi: 10.1097/NND.0b013e3182061ccc.

PMID:
21263276
12.

Mental inertia in the biological sciences.

Shneider AM.

Trends Biochem Sci. 2010 Mar;35(3):125-8. doi: 10.1016/j.tibs.2009.12.004. Epub 2010 Jan 21.

PMID:
20093032
13.

Importance of mRNA secondary structural elements for the expression of influenza virus genes.

Ilyinskii PO, Schmidt T, Lukashev D, Meriin AB, Thoidis G, Frishman D, Shneider AM.

OMICS. 2009 Oct;13(5):421-30. doi: 10.1089/omi.2009.0036.

PMID:
19594376
14.

Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain.

Ilyinskii PO, Nurminskaya MV, Gabai VL, Prilipov AG, Usachev EV, Zakharova LG, Thoidis G, Altstein AD, Shneider AM.

OMICS. 2009 Jun;13(3):211-7. doi: 10.1089/omi.2009.0006.

PMID:
19441878
15.

Four stages of a scientific discipline; four types of scientist.

Shneider AM.

Trends Biochem Sci. 2009 May;34(5):217-23. doi: 10.1016/j.tibs.2009.02.002. Epub 2009 Apr 9.

PMID:
19362484
16.

Development of a vaccine against pandemic influenza viruses: current status and perspectives.

Ilyinskii PO, Thoidis G, Shneider AM.

Int Rev Immunol. 2008;27(6):392-426. doi: 10.1080/08830180802295765. Review.

PMID:
19065349
17.

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

Zhirnov OP, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, Akopova II, Kartashov A, Altstein AD, Ilyinskii PO, Shneider AM.

Influenza Other Respir Viruses. 2007 Mar;1(2):71-9. doi: 10.1111/j.1750-2659.2007.00010.x.

18.

Adjuvant potential of aggregate-forming polyglutamine domains.

Ilyinskii PO, Thoidis G, Sherman MY, Shneider A.

Vaccine. 2008 Jun 19;26(26):3223-6. doi: 10.1016/j.vaccine.2008.03.078. Epub 2008 Apr 18.

PMID:
18467011
19.

The proteosomal degradation of fusion proteins cannot be predicted from the proteosome susceptibility of their individual components.

Ilyinskii PO, Meriin AB, Gabai VL, Usachev EV, Prilipov AG, Thoidis G, Shneider AM.

Protein Sci. 2008 Jun;17(6):1077-85. doi: 10.1110/ps.083443908. Epub 2008 Apr 14.

20.

Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.

Ilyinskii PO, Meriin AB, Gabai VL, Zhirnov OP, Thoidis G, Shneider AM.

Vaccine. 2008 Apr 24;26(18):2177-85. doi: 10.1016/j.vaccine.2008.02.050. Epub 2008 Mar 14.

21.

Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency.

Ilyinskii PO, Gambaryan AS, Meriin AB, Gabai V, Kartashov A, Thoidis G, Shneider AM.

PLoS One. 2008 Jan 16;3(1):e1417. doi: 10.1371/journal.pone.0001417.

22.

Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity.

Ilyinskii PO, Gabai VL, Sunyaev SR, Thoidis G, Shneider AM.

Cell Cycle. 2007 Aug 15;6(16):2043-7. Epub 2007 Jun 12.

PMID:
17700063
23.

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.

Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.

Arch Virol. 2006 May;151(5):921-31. Epub 2005 Nov 15.

PMID:
16292596
24.

Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.

Aleshin SE, Timofeev AV, Khoretonenko MV, Zakharova LG, Pashvykina GV, Stephenson JR, Shneider AM, Altstein AD.

BMC Microbiol. 2005 Aug 2;5:45.

25.

Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.

Khoretonenko MV, Vorovitch MF, Zakharova LG, Pashvykina GV, Ovsyannikova NV, Stephenson JR, Timofeev AV, Altstein AD, Shneider AM.

Immunol Lett. 2003 Dec 15;90(2-3):161-3. Erratum in: Immunol Lett. 2004 Feb 15;91(2-3):255.

PMID:
14687719
26.

Persistence of dyslexia: the Connecticut Longitudinal Study at adolescence.

Shaywitz SE, Fletcher JM, Holahan JM, Shneider AE, Marchione KE, Stuebing KK, Francis DJ, Pugh KR, Shaywitz BA.

Pediatrics. 1999 Dec;104(6):1351-9.

PMID:
10585988
27.

Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures.

Yamaguchi K, Matulka RA, Shneider AM, Toselli P, Trombino AF, Yang S, Hafer LJ, Mann KK, Tao XJ, Tilly JL, Near RI, Sherr DH.

Toxicol Appl Pharmacol. 1997 Dec;147(2):190-203.

PMID:
9439715
28.

Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis.

Yamaguchi K, Near RI, Matulka RA, Shneider A, Toselli P, Trombino AF, Sherr DH.

J Immunol. 1997 Mar 1;158(5):2165-73.

PMID:
9036962
29.

Fluoranthene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor.

Yamaguchi K, Near R, Shneider A, Cui H, Ju ST, Sherr DH.

Toxicol Appl Pharmacol. 1996 Jul;139(1):144-52.

PMID:
8685897
30.

Massive splenomegaly responsive to proguanil and with features of hairy cell leukaemia.

Yermiyahu T, Maislos M, Shneider A, Ben Meir D, Lowenthal MN.

Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):194-6.

PMID:
7778147
31.

[Phenomenon of adapted stabilization of structures and the role of heat shock proteins in its mechanism].

Meerson FZ, Malyshev IIu, Zamotrinskiĭ AV, Shneĭder AB.

Vopr Med Khim. 1992 Jan-Feb;38(1):5-9. Russian.

PMID:
1441297
32.

[Adaptive stabilization of myocardium under the influence of electroacupuncture and cardiac protection].

Meerson FZ, Radzievskiĭ CA, Vovk VI, Vorontsova EIa, Shneider AB, Ustinova EE, Golubeva LIu.

Kardiologiia. 1991 Oct;31(10):72-7. Russian.

PMID:
1753591
33.

Thiamine cardiotropism.

Vinogradov VV, Shneider AB, Senkevich SB.

Cor Vasa. 1991;33(3):254-62.

PMID:
1914476
34.

[Anti-ischemic heart protection using thiamine and nicotinamide].

Shneĭder AB.

Patol Fiziol Eksp Ter. 1991 Jan-Feb;(1):9-10. Russian.

PMID:
1829150
35.

Phenomenon of the adaptive stabilization of sarcoplasmic and nuclear structures in myocardium.

Meerson FZ, Malyshev IYu, Shneider AB.

Basic Res Cardiol. 1991;86 Suppl 3:205-14.

PMID:
1781765
36.

[Comparative evaluation of a protective effect of adaptation to periodic hypoxia and stress in myocardial infarction].

Meerson FZ, Shneĭder AB, Ustinova EE.

Kardiologiia. 1990 Sep;30(9):67-9. Russian. No abstract available.

PMID:
2273743
38.

[Treatment of hymenolepiasis with fenasal].

Baiandina DG, Manevich ME, Medunetskaia EV, Shneĭder AZ.

Med Parazitol (Mosk). 1972 Jul-Aug;41(4):411-3. Russian. No abstract available.

PMID:
5084484
39.

[Utilization of artificial back-contacts for bioelectric prostheses].

Shirokova EA, Shneĭder AIu, Solov'ev LS.

Ortop Travmatol Protez. 1969 Feb;30(2):5-9. Russian. No abstract available.

PMID:
5354115
40.

[A stop headpiece to the "Record" hypodermic syringe].

Shneĭder AI.

Med Prom SSSR. 1965 Nov;19(11):53-4. Russian. No abstract available.

PMID:
5875943

Supplemental Content

Loading ...
Support Center